These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36415837)

  • 1. Secondary Haemophagocytic Lymphohistiocytosis Syndrome (HLH) After Intravesical Instillation of Bacillus Calmette-Guérin (BCG): A Case Report and Review of the Literature.
    Manganas K; Angelara M; Bountzona I; Karamanakos G; Toskas A
    Eur J Case Rep Intern Med; 2022; 9(10):003395. PubMed ID: 36415837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophagocytic syndrome after intravesical bacille Calmette-Guérin instillation.
    Misra S; Gupta A; Symes A; Duncan J
    Scand J Urol; 2014 Jun; 48(3):328-30. PubMed ID: 24070063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophagocytic lymphohistiocytosis after intravesical BCG administration for bladder cancer presenting with multiorgan failure.
    Liatsos GD; Manousopoulou G; Poulaki A; Iliaki A; Mariolis I; Vassilopoulos D
    Access Microbiol; 2023; 5(9):. PubMed ID: 37841100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: A systematic review.
    Cabas P; Rizzo M; Giuffrè M; Antonello RM; Trombetta C; Luzzati R; Liguori G; Di Bella S
    Urol Oncol; 2021 Feb; 39(2):85-92. PubMed ID: 33308969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculous spondylitis following intravesical bcg-instillation in the treatment of transitional cell carcinoma: Case report and systematic review.
    Broekx S; Buelens E
    Clin Neurol Neurosurg; 2020 Jul; 194():105944. PubMed ID: 32480296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic bacillus Calmette-Guérin infection, 'BCGitis', in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer.
    Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
    Eur Urol; 1989; 16(3):161-4. PubMed ID: 2744050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miliary tuberculosis following intravesical Bacillus Calmette and Guérin therapy: A rare complication of a frequent procedure.
    Loued L; Fahem N; Kaddoussi R; Abdelaaly M; Cheikh Mhamed S; Rouatbi N
    Urol Case Rep; 2021 Sep; 38():101655. PubMed ID: 33868941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis.
    Parent ME; Richer M; Liang P
    Clin Rheumatol; 2018 Aug; 37(8):2297-2302. PubMed ID: 29740727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of the Recurrence of Superficial Bladder Cancers: Intravesical Instillation of Bacillus Calmette-guerin Versus Bacillus Calmette-guerin Plus Epirubicin.
    Tozawa K; Okamura T; Yamada Y; Hayashi Y; Sasaki S; Kohri K
    Asian Pac J Cancer Prev; 2000; 1(3):217-220. PubMed ID: 12718668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated Bacillus Calmette-Guérin (BCG) infection with pulmonary and renal involvement: A rare complication of BCG immunotherapy. A case report and narrative review.
    Marques M; Vazquez D; Sousa S; Mesquita G; Duarte M; Ferreira R
    Pulmonology; 2020; 26(6):346-352. PubMed ID: 31711964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Randomized Controlled Study of Intravesical Instillation Therapy of Bacillus Calmette-Guérin vs. Epirubicinin Treating Non-muscular Invasive Bladder Cancer].
    Yang WX; Shao YX; Hu X; Xiong SC; Liu Y; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):326-333. PubMed ID: 33829710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of infectious thoracic aortic aneurysm after intravesical Bacillus Calmette-Guérin instillation therapy for a superficial bladder cancer.
    Koterazawa S; Watanabe J; Uemura Y; Uegaki M; Shirahase T; Taki Y
    Urol Case Rep; 2021 May; 36():101574. PubMed ID: 33552915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reiter's syndrome postintravesical Bacillus Calmette-Guérin instillations.
    Ng KL; Chua CB
    Asian J Surg; 2017 Apr; 40(2):163-165. PubMed ID: 25183290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
    Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
    Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miliary tuberculosis induced by intravesical instillation of bacillus Calmette-Guérin.
    Osorio Aira S; Casadiego Matarranz L; Andrés García N; López Pedreira MR
    Radiologia (Engl Ed); 2019; 61(4):337-340. PubMed ID: 30898332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
    Pommier JD; Ben Lasfar N; Van Grunderbeeck N; Burdet C; Laouénan C; Rioux C; Pierre-Audigier C; Meybeck A; Choudat L; Benchikh A; Nguyen S; Bouvet E; Yeni P; Yazdanpanah Y; Joly V
    Infect Dis (Lond); 2015; 47(10):725-31. PubMed ID: 26077036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
    Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
    Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.
    Fujita N; Hatakeyama S; Momota M; Narita T; Tobisawa Y; Yoneyama T; Yamamoto H; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
    Int J Urol; 2022 Aug; 29(8):867-875. PubMed ID: 35577361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
    Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM
    Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
    Shepherd AR; Shepherd E; Brook NR
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.